Advanced Therapies Europe 2025

02.09.2025
04.09.2025
Hotel Arts Barcelona, Spain
Phacilitate
About Advanced Therapies Europe
Advanced Therapies Europe 2025 will take place from September 2 to 4, 2025, at the Hotel Arts Barcelona (Spain) and will be organized by Phacilitate.
Europe’s Most Exclusive Meeting for Advanced Therapies
They join 500 of the most influential minds in cell and gene therapy for a high-impact, curated experience in Barcelona — one of Europe’s fastest-growing biotech hubs. Across three days of expert content, strategic networking, and invite-only summits, Advanced Therapies Europe 2025 connects therapeutic developers, pharma leaders, CDMOs, and investors in one focused environment.
From plenary sessions and technical workshops to the Women in Advanced Therapies Congress and Investment Summit, every element is designed to accelerate innovation, investment, and commercialisation across the advanced therapies landscape.
What You’ll Gain from Attending
Whether you're launching a new therapy, seeking strategic partnerships, or staying ahead of regulatory and market shifts, Advanced Therapies Europe is built to deliver actionable insight and meaningful connections.
- Expand Your Network – Meet biotech CEOs, pharma strategists, CDMO leaders, and investors shaping the next wave of therapeutic innovation.
- Gain Strategic Insight – Access sessions led by industry experts on regulation, funding trends, scale-up solutions, and commercial strategy.
- Discover What’s Next – Explore the latest advances in cell and gene therapy platforms, biotech technologies, and regenerative medicine.
What is needed to progress ATMPs in Europe? Road to Phacilitate's Advanced Therapies Europe
Ahead of Phacilitate’s Advanced Therapies Europe, they join key industry experts to discuss the current state and trajectory of ATMPs in the EU.
As the world has seen seismic shifts in the funding, technical, and commercial landscape for cell and gene therapies, they recognize the importance of identifying Europe’s evolving role in the global ecosystem, and how they can establish and shore up European bioregions that can translate, develop, and manufacture the next generation of ATMPs.
This is a must-attend, plenary-level meeting for translational, technical, and commercial cell and gene therapy experts.
When?
Thursday, July 10, 2025 · 1:30 p.m.
Speakers:
- Lindsay Davies, CEO. NextCell
- Miguel Forte, CEO. Kiji Therapeutics
- Montse Daban, Director of Science Policy & Internalization. Biocat
Discounts for companies and entities in the BioRegion
20% discount for companies and organizations in the BioRegion of Catalonia using the code BIOCAT20 at registration
Attendees
Therapeutic Developers
Countries